Expert Opinion on Drug Safety

Title Publication Date Language Citations
Multiple sclerosis and pregnancy prescriptions2014/10/21English
Corrigendum2013/02/20English
Related articles2014/04/17English
Related articles2014/06/16English
The safety profile of monoclonal antibodies for chronic lymphocytic leukemia2016/12/04English
Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system2016/11/22English
Manufacturers’ promotion of off-label drug use: implications for drug safety2016/05/23English
Related articles2015/03/17English
Standardized classification unsuitable for spontaneous reporting: the example of osteonecrosis of the jaw2015/05/05English
Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection2015/03/26English
Letter to the Editor: Consideration on “An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency” by Bennett et al.2020/05/19English
Response to: letter to the editor: consideration on ‘an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency’ by bennett et al2020/08/02English
Response to the letter to the editor: Comment on “The need for contraception in patients taking prescription drugs: a review of FDA warning labels, duration of effects, and mechanisms of action” by Zhang et al.2019/03/19English
Statins-induced hepatotoxicity: still more questions than answers2020/10/19English
Allergen immunotherapy for respiratory allergy: to what extent can the risk of systemic reactions be reduced?2020/06/08English
Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency2021/10/22English
Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profile2021/11/12English
A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic2022/11/29English
Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic2022/08/18English
Novel considerations on drug safety in epilepsy2020/12/27English
Monitoring and safety of CAR-T therapy in clinical practice2021/09/23English
Dermatologic adverse events associated with targeted therapies for melanoma2021/11/02English
No association between recent antibiotic use and risk of rheumatoid arthritis: results from two prospective cohort studies2021/08/25English
Long-term safety and effectiveness of vonoprazan for prevention of gastric and duodenal ulcer recurrence in patients on nonsteroidal anti-inflammatory drugs in Japan: a 12-month post-marketing surveillance study2022/10/20English
An update on the safety of ixazomib for the treatment of multiple myeloma2022/09/02English
Related articles2013/06/19English
Related articles2013/04/19English
Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis2011/04/11English
Related articles2014/07/17English
Aspirin and age-related macular degeneration: positives versus negatives2014/04/30English